Shuyang Sun1 article listing Shuyang Sun in Nature Communications, indexed by Paperzzz from Crossref and OSF.Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial Nature Communications